AAAAAA

   
Results: 1-10 |
Results: 10
Use of genetically modified mouse models for evaluation of carcinogenic risk: Considerations for the laboratory animal scientist
Authors: Recio, L Everitt, J
Citation: L. Recio et J. Everitt, Use of genetically modified mouse models for evaluation of carcinogenic risk: Considerations for the laboratory animal scientist, COMPAR MED, 51(5), 2001, pp. 399-405
Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene
Authors: Saranko, CJ Meyer, KG Pluta, LJ Henderson, RF Recio, L
Citation: Cj. Saranko et al., Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene, MUT RES-F M, 473(1), 2001, pp. 37-49
Induction and time-dependent accumulation of micronuclei in peripheral blood of transgenic p53 +/- mice, Tg.AC (v-Ha-ras) and parental wild-type (C57BL/6 and FVB/N) mice exposed to benzene by inhalation
Authors: Healy, LN Pluta, LJ James, RA Janszen, DB Torous, D French, JE Recio, L
Citation: Ln. Healy et al., Induction and time-dependent accumulation of micronuclei in peripheral blood of transgenic p53 +/- mice, Tg.AC (v-Ha-ras) and parental wild-type (C57BL/6 and FVB/N) mice exposed to benzene by inhalation, MUTAGENESIS, 16(2), 2001, pp. 163-168
Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms
Authors: Recio, L Steen, AM Pluta, LJ Meyer, KG Saranko, CJ
Citation: L. Recio et al., Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms, CHEM-BIO IN, 135, 2001, pp. 325-341
Inhibition of cytochrome P450 2E1 decreases, but does not eliminate, genotoxicity mediated by 1,3-butadiene
Authors: Jackson, TE Lilly, PD Recio, L Schlosser, PM Medinsky, MA
Citation: Te. Jackson et al., Inhibition of cytochrome P450 2E1 decreases, but does not eliminate, genotoxicity mediated by 1,3-butadiene, TOXICOL SCI, 55(2), 2000, pp. 266-273
Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assessment
Authors: Gulezian, D Jacobson-Kram, D McCullough, CB Olson, H Recio, L Robinson, D Storer, R Tennant, R Ward, JM Neumann, DA
Citation: D. Gulezian et al., Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assessment, TOX PATHOL, 28(3), 2000, pp. 482-499
Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: Evidence of chromosomal recombination
Authors: Boley, SE Anderson, EE French, JE Donehower, LA Walker, DB Recio, L
Citation: Se. Boley et al., Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: Evidence of chromosomal recombination, CANCER RES, 60(11), 2000, pp. 2831-2835
Persistence of N7-(2,3,4-trihydroxybutyl)guanine adducts in the livers of mice and rats exposed to 1,3-butadiene
Authors: Oe, T Kambouris, SJ Walker, VE Meng, QX Recio, L Wherli, S Chaudhary, AK Blair, IA
Citation: T. Oe et al., Persistence of N7-(2,3,4-trihydroxybutyl)guanine adducts in the livers of mice and rats exposed to 1,3-butadiene, CHEM RES T, 12(3), 1999, pp. 247-257
Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens
Authors: Dean, SW Brooks, TM Burlinson, B Mirsalis, J Myhr, B Recio, L Thybaud, V
Citation: Sw. Dean et al., Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens, MUTAGENESIS, 14(1), 1999, pp. 141-151
Expression and distribution of cytochrome P450 2E1 in B6C3F1 mouse liver and testes
Authors: Healy, LN Pluta, LJ Recio, L
Citation: Ln. Healy et al., Expression and distribution of cytochrome P450 2E1 in B6C3F1 mouse liver and testes, CHEM-BIO IN, 121(2), 1999, pp. 199-207
Risultati: 1-10 |